{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:14:51Z","timestamp":1793369691329,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ahj.2025.03.023","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T11:59:13Z","timestamp":1744113553000},"page":"65-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Design and rationale of the drug-coated balloon coronary angioplasty versus stenting for treatment of disease adjacent to a chronic total occlusion (Co-CTO) trial"],"prefix":"10.1016","volume":"288","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2585-9631","authenticated-orcid":false,"given":"Yvemarie B.O.","family":"Somsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben W.","family":"de Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel","family":"Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf W.","family":"Sprengers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels J.","family":"Verouden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimmer E.P.M.","family":"Claessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan A.","family":"Kleijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos W.R.","family":"Twisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 P.","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Spratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas T.","family":"Rissanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret B.","family":"McEntegart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Knaapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ahj.2025.03.023_bib0001","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ahj.2010.04.015","article-title":"Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis","volume":"160","author":"Joyal","year":"2010","journal-title":"Am Heart J"},{"issue":"18","key":"10.1016\/j.ahj.2025.03.023_bib0002","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jacc.2016.08.034","article-title":"The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe: The RECHARGE Registry","volume":"68","author":"Maeremans","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2025.03.023_bib0003","first-page":"911","article-title":"Percutaneous Coronary Revascularization for Chronic Total Occlusions: A Novel Predictive Score of Technical Failure Using Advanced Technologies","volume":"9","author":"Galassi","year":"2016","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"6","key":"10.1016\/j.ahj.2025.03.023_bib0004","first-page":"1027","article-title":"Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience from the Japanese retrograde summit registry","volume":"87","author":"Habara","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"issue":"18","key":"10.1016\/j.ahj.2025.03.023_bib0005","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/heartjnl-2015-308891","article-title":"Hybrid approach improves success of chronic total occlusion angioplasty","volume":"102","author":"Wilson","year":"2016","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.ahj.2025.03.023_bib0006","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/CIRCULATIONAHA.119.039797","article-title":"Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention","volume":"140","author":"Brilakis","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2025.03.023_bib0007","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jjcc.2022.08.008","article-title":"Angioscopic findings 1 year after percutaneous coronary intervention for chronic total occlusion","volume":"81","author":"Fukuizumi","year":"2023","journal-title":"J Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2025.03.023_bib0008","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.4244\/EIJ-D-22-01096","article-title":"Contemporary issues of percutaneous coronary intervention in heavily calcified chronic total occlusions: an expert review from the European CTO Club","volume":"19","author":"Mashayekhi","year":"2023","journal-title":"EuroIntervention"},{"issue":"17","key":"10.1016\/j.ahj.2025.03.023_bib0009","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1053\/euhj.2001.2752","article-title":"The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions; final results of the Magic 5L Study","volume":"22","author":"Foley","year":"2001","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ahj.2025.03.023_bib0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcin.2009.11.009","article-title":"Impact of multiple and long sirolimus-eluting stent implantation on 3-year clinical outcomes in the j-Cypher Registry","volume":"3","author":"Shirai","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.ahj.2025.03.023_bib0011","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jcin.2011.07.016","volume":"4","author":"Claessen","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.ahj.2025.03.023_bib0012","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.amjcard.2012.03.031","article-title":"Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry)","volume":"110","author":"Caputo","year":"2012","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2025.03.023_bib0013","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/1358863X20927791","article-title":"Drug-coated balloons: Technical and clinical progress","volume":"25","author":"Ang","year":"2020","journal-title":"Vasc Med"},{"issue":"3","key":"10.1016\/j.ahj.2025.03.023_bib0014","first-page":"569","article-title":"Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept","volume":"101","author":"R\u00e4s\u00e4nen","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.ahj.2025.03.023_bib0015","first-page":"2003","article-title":"Effect of Drug-Coated Balloons in Native Coronary Artery Disease Left with a Dissection","volume":"8","author":"Cortese","year":"2015","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"10150","key":"10.1016\/j.ahj.2025.03.023_bib0016","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial","volume":"392","author":"Jeger","year":"2018","journal-title":"The Lancet"},{"issue":"10194","key":"10.1016\/j.ahj.2025.03.023_bib0017","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","article-title":"Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial","volume":"394","author":"Rissanen","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ahj.2025.03.023_bib0018","first-page":"292","article-title":"Clinical Impact of Drug-Coated Balloon\u2013Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease","volume":"16","author":"Shin","year":"2023","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"11","key":"10.1016\/j.ahj.2025.03.023_bib0019","first-page":"1153","article-title":"The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease","volume":"6","author":"Costopoulos","year":"2013","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"14","key":"10.1016\/j.ahj.2025.03.023_bib0020","doi-asserted-by":"crossref","first-page":"e1589","DOI":"10.4244\/EIJV11I14A309","article-title":"Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the \u201cno more metallic cages\u201d multicentre pilot experience","volume":"11","author":"Ielasi","year":"2016","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.ahj.2025.03.023_bib0021","doi-asserted-by":"crossref","first-page":"163","DOI":"10.23736\/S2724-5683.23.06352-4","article-title":"Procedural and one-year outcomes following drug-eluting stent and drug-coated balloon combination for the treatment of de novo diffuse coronary artery disease: the HYPER Study","volume":"72","author":"Buono","year":"2024","journal-title":"Minerva Cardiol Angiol"},{"issue":"2","key":"10.1016\/j.ahj.2025.03.023_bib0022","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1016\/j.ahj.2025.03.023_bib0023","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.120.046754","article-title":"Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations","volume":"143","author":"Ybarra","year":"2021","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ahj.2025.03.023_bib0024","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00392-013-0609-7","article-title":"Drug-coated balloons for treatment of coronary artery disease: Updated recommendations from a consensus group","volume":"102","author":"Kleber","year":"2013","journal-title":"Clinical Research in Cardiology"},{"issue":"10","key":"10.1016\/j.ahj.2025.03.023_bib0025","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.4244\/EIJ-D-23-00838","article-title":"Same-day discharge after large-bore access in percutaneous coronary intervention of chronic total coronary occlusions","volume":"20","author":"Somsen","year":"2024","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.ahj.2025.03.023_bib0026","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcin.2010.01.010","article-title":"The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of \"oculostenotic\" reintervention in patients with intermediate lesions","volume":"3","author":"Uchida","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.ahj.2025.03.023_bib0027","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","volume":"37","author":"Mintz","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.ahj.2025.03.023_bib0028","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2025.03.023_bib0029","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jcin.2014.07.031","article-title":"Coronary computed tomographic prediction rule for time-efficient guidewire crossing through chronic total occlusion: insights from the CT-RECTOR multicenter registry (Computed Tomography Registry of Chronic Total Occlusion Revascularization)","volume":"8","author":"Opolski","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.ahj.2025.03.023_bib0030","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jcmg.2021.04.013","article-title":"Effect of Coronary CTA on Chronic Total Occlusion Percutaneous Coronary Intervention: A Randomized Trial","volume":"14","author":"Hong","year":"2021","journal-title":"JACC Cardiovascular imaging"},{"issue":"4","key":"10.1016\/j.ahj.2025.03.023_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005800","volume":"10","author":"Yu","year":"2017","journal-title":"Circulation Cardiovascular imaging"},{"issue":"10","key":"10.1016\/j.ahj.2025.03.023_bib0032","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jacc.2020.06.076","article-title":"Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies","volume":"76","author":"Abdelrahman Khaled","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"issue":"9865","key":"10.1016\/j.ahj.2025.03.023_bib0033","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","article-title":"Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial","volume":"381","author":"Byrne","year":"2013","journal-title":"The Lancet"},{"issue":"24","key":"10.1016\/j.ahj.2025.03.023_bib0034","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.jacc.2018.09.013","article-title":"Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial","volume":"72","author":"Zhang","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2025.03.023_bib0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcin.2017.10.024","article-title":"A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial","volume":"11","author":"Baan","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"10.1016\/j.ahj.2025.03.023_bib0036","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","article-title":"A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study","volume":"60","author":"Latib","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.ahj.2025.03.023_bib0037","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.97.14.1355","article-title":"Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions","volume":"97","author":"Kornowski","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2025.03.023_bib0038","first-page":"30","article-title":"European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club","volume":"3","author":"Di Mario","year":"2007","journal-title":"EuroIntervention"},{"issue":"17","key":"10.1016\/j.ahj.2025.03.023_bib0039","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary Revascularization: An Expert Consensus Document From the Society for Cardiovascular Angiography and Interventions (SCAI)","volume":"62","author":"Moussa","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1016\/j.ahj.2025.03.023_bib0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.gheart.2018.08.004","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"13","author":"Thygesen","year":"2018","journal-title":"Glob Heart"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032500105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032500105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:59:26Z","timestamp":1762077566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287032500105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"alternative-id":["S000287032500105X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2025.03.023","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and rationale of the drug-coated balloon coronary angioplasty versus stenting for treatment of disease adjacent to a chronic total occlusion (Co-CTO) trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2025.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}